NCT05168605Recruiting
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 9 Dec 2021
- Start date
- 27 Jul 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- University of Texas Southwestern Medical Center
- Diseases
- High blood pressure, Type 2 diabetes
- NCT number
- NCT05168605
What you commit to
- Study type: Interventional
- Planned participants: 100
- From 27 Jul 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current oral steroid use
Other illness
- History of solid organ transplant
Other
- Language other than English or Spanish
Who the study is looking for
- Adult patients ages 18-60
- Spanish or English speaking
- Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record)
- Hemoglobin A1C\>8 in last 6 months (based on medical record)
- Not pregnant
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.